|
MORE People are Talking MORE Often on MORE Diverse and Intriguing Topics.
Click on the icon to download the media alert for the fourth quarter of 2010.
March
SPECIAL ISSUE: Streamlining the Drug Development Process: From Discovery to Commercialization — Experts agree drug discovery and development efforts should begin and end with the patient. Industry experts from all sectors of the industry provide their insights on the different areas that impact patient well-being during the complex R&D and commercialization process, from target identification and validation to lead optimization to early clinical safety and efficacy to Phase I through Phase III trials to registration to post-launch activities. What piece of the puzzle do you have? Tell us what you think needs to change to make all or any part of the process more efficient. Send your insights to: Taren Grom, Editor.
April
Cover Story Forum: Software as a Service (SaaS)
Clinical Topic: Specialty CROs
Marketing Topic: Brand Stewardship: Best Practices for Maintaining Creative Integrity, and Client Services
Showcase Topic: IRBs
Industry BIO:TBD
May
Cover Story Forum: Electronic Health Records
Clinical Topic: Green Clinical
Industry Topic: Leaders for Today and Tomorrow — HBA's Rising Stars
Showcase Topic: Anticounterfeiting Packaging
Industry BIO:TBD
June
Cover Story Forum: Adaptive Clinical Trials: The Next Phase
Clinical Topic: Special DIA Preview
Showcase Topic: IP Infringement
July/August
Sixth Annual PharmaVOICE 100.
The PharmaVOICE 100 recognizes some of the most inspiring people in the life-sciences industry, who have been determined by you, our readers.
The PharmaVOICE 100 are individuals who motivate and influence; they are corporate leaders in research and development, marketing, technology, creativity, strategy, medicine, to name just a few; and they are positively impacting their peers, their colleagues, their companies, their communities, as well as the industry at large through their actions.
The PharmaVOICE 100 is one of the most anticipated issues of the year. Even if your advertising budgets are limited, this is the one issue you don't want to miss.

|